JP2022523050A5 - - Google Patents

Info

Publication number
JP2022523050A5
JP2022523050A5 JP2021543230A JP2021543230A JP2022523050A5 JP 2022523050 A5 JP2022523050 A5 JP 2022523050A5 JP 2021543230 A JP2021543230 A JP 2021543230A JP 2021543230 A JP2021543230 A JP 2021543230A JP 2022523050 A5 JP2022523050 A5 JP 2022523050A5
Authority
JP
Japan
Prior art keywords
acid sequence
nucleic acid
raav
mammal
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021543230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022523050A (ja
JP7624727B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/014838 external-priority patent/WO2020154535A1/en
Publication of JP2022523050A publication Critical patent/JP2022523050A/ja
Publication of JP2022523050A5 publication Critical patent/JP2022523050A5/ja
Application granted granted Critical
Publication of JP7624727B2 publication Critical patent/JP7624727B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021543230A 2019-01-23 2020-01-23 合理的設計により増強された新規なaavウイルスによる網膜における高効率の形質導入および側方への広がり Active JP7624727B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962795695P 2019-01-23 2019-01-23
US62/795,695 2019-01-23
PCT/US2020/014838 WO2020154535A1 (en) 2019-01-23 2020-01-23 Highly efficient transduction and lateral spread in the retina by a novel aav virus enhanced by rational design

Publications (3)

Publication Number Publication Date
JP2022523050A JP2022523050A (ja) 2022-04-21
JP2022523050A5 true JP2022523050A5 (cg-RX-API-DMAC7.html) 2023-02-06
JP7624727B2 JP7624727B2 (ja) 2025-01-31

Family

ID=71737005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021543230A Active JP7624727B2 (ja) 2019-01-23 2020-01-23 合理的設計により増強された新規なaavウイルスによる網膜における高効率の形質導入および側方への広がり

Country Status (7)

Country Link
US (1) US12649004B2 (cg-RX-API-DMAC7.html)
EP (1) EP3914229A4 (cg-RX-API-DMAC7.html)
JP (1) JP7624727B2 (cg-RX-API-DMAC7.html)
CN (1) CN113347962B (cg-RX-API-DMAC7.html)
AU (1) AU2020212026B2 (cg-RX-API-DMAC7.html)
CA (1) CA3125294A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020154535A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024223696A1 (en) * 2023-04-24 2024-10-31 Universiteit Gent Compounds to treat inherited retinal disease
CN121046460A (zh) * 2024-05-31 2025-12-02 上海朗昇生物科技有限公司 用于治疗Prom1相关视网膜疾病的新型治疗药物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0977880A2 (en) 1997-04-21 2000-02-09 University Of Florida Materials and methods for treatment of retinal diseases
EP1463805B1 (en) 2001-12-17 2014-10-22 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
AU2003274397A1 (en) 2002-06-05 2003-12-22 University Of Florida Production of pseudotyped recombinant aav virions
WO2005003321A2 (en) 2003-07-06 2005-01-13 Roger Williams Medical Center Methods of producing differentiated hematopoietic cells for treatment of cytopenia
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
US20120322861A1 (en) 2007-02-23 2012-12-20 Barry John Byrne Compositions and Methods for Treating Diseases
HUE041571T2 (hu) 2010-04-23 2019-05-28 Univ Florida RAAV-guanilát-cikláz-készítmények és ejárások 1-es típusú Leber-féle veleszületett vakság (LCA1) kezelésére
US9249425B2 (en) 2011-05-16 2016-02-02 The Trustees Of The University Of Pennslyvania Proviral plasmids and production of recombinant adeno-associated virus
AU2014216160B2 (en) 2013-02-15 2017-03-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services AAV8 retinoschisin expression vector for treating X-linked retinoschisis
JP2016517278A (ja) 2013-03-15 2016-06-16 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia スタッファー/フィラーポリヌクレオチド配列を含むベクターおよびその使用方法
EP3113787B1 (en) 2014-03-04 2019-12-04 University of Florida Research Foundation, Inc. Improved raav vectors and methods for transduction of photoreceptors and rpe cells
ES2822551T3 (es) 2014-03-17 2021-05-04 Adverum Biotechnologies Inc Composiciones y métodos para la expresión génica mejorada en células de los conos
WO2015152941A1 (en) 2014-04-04 2015-10-08 Siemens Aktiengesellschaft Combing multiple trending models for photovoltaic plant output forecasting
LT3137497T (lt) * 2014-05-02 2021-07-26 Genzyme Corporation Aav vektoriai, skirti tinklainės ir cns genų terapijai
WO2016149664A1 (en) 2015-03-18 2016-09-22 University Of Florida Research Foundation, Inc. Methods and compositions for restoration of cone function in bcm
WO2016183297A1 (en) 2015-05-12 2016-11-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
WO2017070491A1 (en) 2015-10-23 2017-04-27 Applied Genetic Technologies Corporation Ophthalmic formulations
US20170348387A1 (en) 2016-02-29 2017-12-07 The Trustees Of The University Of Pennsylvania Aav-mediated gene therapy for nphp5 lca-ciliopathy
JP6994018B2 (ja) 2016-07-26 2022-01-14 バイオマリン ファーマシューティカル インコーポレイテッド 新規アデノ随伴ウイルスキャプシドタンパク質
EP3585883A4 (en) 2017-02-21 2021-04-14 University of Florida Research Foundation, Incorporated MODIFIED AAV CAPSID PROTEINS AND USES THEREOF
US20200270635A1 (en) 2017-05-05 2020-08-27 Voyager Therapeutics, Inc. Modulatory polynucleotides
WO2019144077A1 (en) 2018-01-22 2019-07-25 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Methods and compositions for treating genetically linked diseases of the eye
JP2022530845A (ja) 2019-04-27 2022-07-04 オクジェン アイエヌシー. 眼疾患に対するadeno随伴ウイルス連ウイルスベクター媒介遺伝子治療
JP7707081B2 (ja) 2019-05-17 2025-07-14 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル 網膜細胞を標的とした最適化された遺伝子治療
WO2022011081A1 (en) 2020-07-09 2022-01-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cell lines that produce human retinoschisin proteins and uses thereof
IL299927A (en) 2020-07-29 2023-03-01 Univ Florida Improved adeno-associated virus-mediated therapies for X-linked retinoschisis
US12621783B2 (en) 2020-07-31 2026-05-05 Beijing Xiaomi Mobile Software Co., Ltd. Method and apparatus for random access
WO2023081739A1 (en) 2021-11-03 2023-05-11 Teamedon International, Inc. Methods of treating human x-linked retinoschisis using gene therapy
EP4511496A4 (en) 2022-04-18 2026-06-24 Abeona Therapeutics Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF DOMINANT OPTIC ATROPHY AND X-RELATED RETINOSCHISISIS
CN114848850B (zh) 2022-04-28 2023-12-15 武汉中眸生物科技有限责任公司 Rs1基因在制备xlrs治疗剂中的应用及治疗剂

Similar Documents

Publication Publication Date Title
EP4051694B1 (en) Aav vector variants for ocular gene delivery
JP2022065003A (ja) パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質
JP7289306B2 (ja) 網膜障害を治療するための組成物及び方法
EA038695B1 (ru) Способы и композиции для переноса генов по сосудистой сети
US20110117058A1 (en) Method of treating genetic disorders
WO2014143932A1 (en) Synthetic adeno-associated virus inverted terminal repeats
JP2022522776A5 (cg-RX-API-DMAC7.html)
JP2019524090A5 (cg-RX-API-DMAC7.html)
RU2019103488A (ru) Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12
JP2022539156A (ja) ヒアルロン酸を用いた眼組織へのaav媒介形質導入の増強
EP3628011A1 (en) Gene therapy for ciliopathies
JP2023545229A5 (cg-RX-API-DMAC7.html)
JP2023513004A5 (cg-RX-API-DMAC7.html)
WO2024240113A1 (zh) 一种腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用
JP2024105661A (ja) 眼疾患に対するadeno随伴ウイルス連ウイルスベクター媒介遺伝子治療
CN114126667A (zh) 使用糖苷水解酶的基因疗法载体向视网膜细胞的改进递送
Kim et al. AAV-based gene therapies for neovascular AMD
JP7627961B2 (ja) バルデー・ビードル症候群の遺伝子治療
CN113347962B (zh) 通过合理设计增强的新型aav病毒在视网膜中的高效转导和侧向扩散
CN113795279B (zh) 靶向akt通路的神经保护性基因疗法
KR20260065692A (ko) 아데노-관련 바이러스 변이체 및 그의 용도
CN112063625A (zh) 编码arl2bp的核酸及其应用
WO2026076753A1 (zh) 携带tyr基因的重组腺相关病毒载体及其在治疗oca1疾病中的应用
Zheng et al. Transduction of mouse retina by insect cell packaged recombinant adeno-associated viruses and their mutants via intravitreal injection
HK40090167A (en) Construction and application of an in vivo anti-vegf antibody expression system